NFκB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses

Cited by (167)

Items 101–167 of 167

1. Structural overview and perspectives of the nuclear receptors, a major family as the direct targets for<?A3B2 ACK?>small-molecule drugs
   Fengwei Li, Chun Meng Song, Youming Zhang, Dalei Wu · 2021 · Acta Biochimica et Biophysica Sinica
2. Synthesis of novel steroidal agonists, partial agonists, and antagonists for the glucocorticoid receptor
   Zhuang Jin, Hua Lin, Sathish Srinivasan, Jerome C. Nwachukwu, Nelson E. Bruno, Patrick R. Griffin, K.W. Nettles, Theodore M. Kamenecka · 2016 · Bioorganic & Medicinal Chemistry Letters
3. Interference of Boswellic Acids with the Ligand Binding Domain of the Glucocorticoid Receptor
   Thomas Scior, Moritz Verhoff, Itzel Gutierrez-Aztatzi, Hermann P. T. Ammon, Stefan Laufer, Oliver Werz · 2014 · Journal of Chemical Information and Modeling
4. Subtype-Specific Modulation of Estrogen Receptor–Coactivator Interaction by Phosphorylation
   Inga M. Tharun, Lidia Nieto, Christian Haase, Marcel Scheepstra, Mark Balk, Sabine Möcklinghoff, Wencke Adriaens, Sonja A. Dames, Luc Brunsveld · 2014 · ACS Chemical Biology
5. The nuclear receptor signalling scaffold: insights from full‐length structures
   Jerome C. Nwachukwu, K.W. Nettles · 2012 · The EMBO Journal
6. Decoding estrogen receptor and GPER biology: structural insights and therapeutic advances in ERα−positive breast cancer
   Taniya Saha, Kiven Erique Lukong · 2025 · Frontiers in Oncology
7. Longitudinal Molecular Imaging of Progesterone Receptor Reveals Early Differential Response to Endocrine Therapy in Breast Cancer with an Activating ESR1 Mutation
   Manoj Kumar, Kelley Salem, Justin J. Jeffery, Yongjun Yan, Aparna M. Mahajan, Amy M. Fowler · 2020 · Journal of Nuclear Medicine
8. Structure-Based Approach for the Discovery of Novel Selective Estrogen Receptor Modulators
   Camillo Rosano, Emilia Stec‐Martyna, Rosamaria Lappano, Marcello Maggiolini · 2011 · Current Medicinal Chemistry
9. Recent advances in peptidomimetics antagonists targeting estrogen receptor α-coactivator interaction in cancer therapy
   Weirong Qin, Mingsheng Xie, Xuan Qin, Qi Fang, Feng Yin, Zigang Li · 2018 · Bioorganic & Medicinal Chemistry Letters
10. Human Estrogen Receptor Alpha Antagonists, Part 3: 3-D Pharmacophore and 3-D QSAR Guided Brefeldin A Hit-to-Lead Optimization toward New Breast Cancer Suppressants
    Nezrina Kurtanović, Nevena Tomašević, Sanja Lj. Matić, Eleonora Proia, Manuela Sabatino, Lorenzo Antonini, Milan P. Mladenović, Rino Ragno · 2022 · Molecules
11. The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer
    Maria Russi, Domenico Marson, Alice Fermeglia, Suzana Aulić, Maurizio Fermeglia, Erik Laurini, Sabrina Pricl · 2021 · Pharmacology & Therapeutics
12. Nuclear Hormone Receptor Architecture - Form and Dynamics: The 2009 FASEB Summer Conference on Dynamic Structure of the Nuclear Hormone Receptors
    Iain J. McEwan, Ann M. Nardulli · 2009 · Nuclear Receptor Signaling
13. Estrogen Receptor Alpha and ESR1 Mutations in Breast Cancer
    Jaymin M. Patel, Rinath M. Jeselsohn · 2022 · Advances in experimental medicine and biology
14. Asymmetric allostery in estrogen receptor-α homodimers drives responses to the ensemble of estrogens in the hormonal milieu
    Charles K. Min, Jerome C. Nwachukwu, Yingwei Hou, Robin J. Russo, Alexandra Papa, Jian Min, Rouming Peng, Sung Hoon Kim, Yvonne Ziegler, Erumbi S. Rangarajan et al. · 2024 · Proceedings of the National Academy of Sciences
15. Current Therapeutic Opportunities for Estrogen Receptor Mutant Breast Cancer
    Murugesan Palaniappan · 2024 · Biomedicines
16. Oxabicycloheptene Sulfonate Protects Against β-Amyloid-induced Toxicity by Activation of PI3K/Akt and ERK Signaling Pathways Via GPER1 in C6 Cells
    Lijuan Deng, Cheng Chen, Jun Wu, Caihua Wang, Hai‐Bing Zhou, Jian Huang · 2017 · Neurochemical Research
17. Optimization of small molecule degraders and antagonists for targeting estrogen receptor based on breast cancer: current status and future
    Jiaqi Yao, Yiran Tao, Zelin Hu, Junjie Li, Ziyi Xue, Ya Zhang, Yi Lei · 2023 · Frontiers in Pharmacology
18. Steroids - Basic Science
    Hassan S. Abduljabbar · 2012 · InTech eBooks
19. Ligand-Induced Allosteric Effects Governing SR Signaling
    C. Denise Okafor, Jennifer K. Colucci, Eric A. Ortlund · 2019 · Nuclear Receptor Research
20. Physiological and Pathological Roles of Estrogen Receptor
    Kenneth Steven Korach, Sylvia C. Hewitt, Katherine J. Hamilton, Yin Li, J Tyler Ramsey, Marleny Garcia, Emilie Mathura, Yukitomo Arao · 2018 · Cancer drug discovery and develogment/Cancer drug discovery and development
21. Dynamic changes in binding interaction networks of sex steroids establish their non-classical effects
    Mónika Bálint, Norbert Jeszenői, István Horváth, István M. Ábrahám, Csaba Hetényi · 2017 · Scientific Reports
22. Design, synthesis, biological evaluation and crystal structure determination of dual modulators of carbonic anhydrases and estrogen receptors
    Annachiara Tinivella, Jerome C. Nwachukwu, Andrea Angeli, Francesca Foschi, Anna Laura Benatti, Luca Pinzi, Tina Izard, Marta Ferraroni, R. Erumbi, Michael S. Christodoulou et al. · 2022 · European Journal of Medicinal Chemistry
23. Human Estrogen Receptor α Antagonists. Part 1: 3-D QSAR-Driven Rational Design of Innovative Coumarin-Related Antiestrogens as Breast Cancer Suppressants through Structure-Based and Ligand-Based Studies
    Nezrina Mihović, Nevena Stanković, Sanja Lj. Matić, Marina M. Mitrović, Danijela A. Kostić, Manuela Sabatino, Lorenzo Antonini, Rino Ragno, Milan P. Mladenović · 2021 · Journal of Chemical Information and Modeling
24. A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy
    Irida Kastrati, Marton I. Siklos, Svitlana D. Brovkovych, Gregory R. J. Thatcher, Jonna M. Frasor · 2017 · Hormones and Cancer
25. The kinome associated with estrogen receptor-positive status in human breast cancer
    M. C. Bruce, Donna M. McAllister, Leigh C. Murphy · 2014 · Endocrine Related Cancer
26. Responses of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) in MCF-7 cells are culture condition dependent
    E. Immonen, Raisa Serpi, Kirsi Vähäkangas, Päivi K. Myllynen · 2009 · Chemico-Biological Interactions
27. Does the oestrogen receptor encourage oestrogenicity in environmental pollutants? The case of 4-nonylphenol
    L.A. Graham, I.C. Shaw · 2011 · SAR and QSAR in environmental research
28. Inability to confirm estrogenicity of the heterocyclic amine PhIP in two in vitro assays
    Richard Evans, Sinikka Rahte, Andreas Kortenkamp · 2009 · Toxicology in Vitro
29. New Insights in Estrogen Receptor (ER) Biology and Implications for Treatment
    Aabha Oza, Cynthia X. Ma · 2017 · Current Breast Cancer Reports
30. Approaches to Introduce Helical Structure in Cysteine‐Containing Peptides with a Bimane Group
    Aimee J. Horsfall, Daniel P. McDougal, Denis B. Scanlon, John B. Bruning, Andrew David Abell · 2021 · ChemBioChem
31. Dynamic Docking of Macrocycles in Bound and Unbound Protein Structures with DynaDock
    Maximilian Meixner, Martin Zachmann, Sebastian Metzler, Jonathan Scheerer, Martin Zacharias, Iris Antes · 2022 · Journal of Chemical Information and Modeling
32. Synthesis and estrogenic activity of BODIPY-labeled estradiol conjugates
    Miroslav Peřina, Rita Börzsei, Henrietta Ágoston, Tamás Hlogyik, Miklós Poór, Réka Laczkó-Rigó, Csilla Özvegy‐Laczka, Gyula Batta, Csaba Hetényi, Veronika Vojáčková et al. · 2024 · European Journal of Pharmaceutical Sciences
33. Drug Design Approaches to Manipulate the Agonist-Antagonist Equilibrium in Steroid Receptors
    Scott J., Paolo Conti, Wim H.A. Dokter, Pedro H., Jacob de · 2012 · InTech eBooks
34. Hormone-Responsive Cancers
    Myles A Brown, Laura Cato, Rinath M. Jeselsohn · 2019 · Elsevier eBooks
35. Erratum: Corrigendum: NFκB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses
    K.W. Nettles, John B. Bruning, Germán A. Gil, Jason Nowak, Sanjay K Sharma, Johnnie B. Hahm, Kristen S. Kulp, Richard B. Hochberg, Hai‐Bing Zhou, John A. Katzenellenbogen et al. · 2008 · Nature Chemical Biology
36. Importance of Receptor Conformations in Docking Calculation-Based Risk Assessment for Endocrine Disruptors against Estrogen Receptor α
    Hitoshi Kesamaru, Keitaro Suyama, Takeru Nose · 2019 · ACS Omega
37. Bile acids target an exposed cavity in the glucocorticoid receptor modulating receptor self-assembly, chromatin binding and transcriptional activity
    Alba Jiménez‐Panizo, Thomas A. Johnson, Kaustubh Wagh, Andrea Alegre‐Martí, Inés Montoya-Novoa, Agustina L. Lafuente, Ulrich Eckhard, Luis Angel Rodríguez‐Lumbreras, Le Hoang, Martín Stortz et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
38. Sparse networks of conformational fluctuations communicate signals within proteins
    Kaitlin Trenfield, Milo M. Lin · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
39. The Red Shift in Estrogen Research: An Estrogen-Receptor Targeted aza-BODIPY–Estradiol Fluorescent Conjugate
    Tamás Hlogyik, Noémi Bózsity, Rita Börzsei, Benjamin Kovács, Péter Labos, Csaba Hetényi, Mónika Kiricsi, Ildikó Huliák, Zoltán Kele, Miklós Poór et al. · 2025 · International Journal of Molecular Sciences
40. Discovery of a novel small molecule degrader of wild type and mutant estrogen receptors using DNA encoded libraries
    Anil Kumar Devakrishnan, Chandrashekhar Madasu, Yong Wang, Ram K. Modukuri, Kurt M. Bohren, Kevin R. MacKenzie, Damian W. Young, Suzanne A.W. Fuqua, Martin Matthew Matzuk, Murugesan Palaniappan · 2025 · npj Breast Cancer
41. Characterization of ESR1 alterations in patients with breast and gynecologic cancers
    Gargi Dan Basu, Paige Innis, Angela K. Deem, Arthur Starodynov, Sameer S. Udhane, Szabolcs Szelinger, M. Wang, Janine R. Lobello, Frederick L. Baehner, Jean–Paul De La O et al. · 2026 · Breast Cancer Research
42. Therapeutic Strategies to Target Activating Estrogen Receptor α Mutations
    Kristine Donahue, Wei Xu · 2021 · Springer eBooks
43. How drug resistance takes shape
    Rinath M. Jeselsohn, Myles A Brown · 2016 · eLife
44. Structural evolution of the estrogen receptor regulatory domain
    Daniel P. McDougal, Jordan L. Pederick, Linda Shearwin‐Whyatt, Frank Grützner, John B. Bruning · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
45. A ternary switch model governing ERα ligand binding domain conformation
    Daniel P. McDougal, Jordan L. Pederick, Scott J. Novick, Blagojce Jovcevski‬, Annmaree K. Warrender, Bruce D. Pascal, Patrick R. Griffin, John B. Bruning · 2025 · Nature Communications
46. MTD-PLS and docking study for a series of substituted 2-phenylindole derivatives with oestrogenic activity
    Edward Paul Șeclăman, Alina Bora, Sorin I. Avram, Zeno Simon, Ludovic Kurunczi · 2011 · Chemical Papers
47. CLUES ABOUT ESTROGEN AND ANTIESTROGEN ACTION FROM X-RAY CRYSTALLOGRAPHY
    Geoffrey L. Greene, Virgil Craig Jordan · 2013 · IMPERIAL COLLEGE PRESS eBooks
48. Drug discovery of N-methyl-pyrazole derivatives as potent selective estrogen receptor degrader (SERD) for the treatment of breast cancer
    Rupeng Dai, Xueting Bao, Chao Liu, Xunkai Yin, Zhenzhen Zhu, Zhe Zheng, Bo Wang, Kundi Yang, Hongmei Wen, Wei Li et al. · 2024 · European Journal of Medicinal Chemistry
49. Structure-Based Ligand Design I
    Hongmao Sun · 2015 · Elsevier eBooks
50. Fast-tracking steroid receptor crystallization
    Sylvie Mader · 2008 · Nature Chemical Biology
51. Structural Insights into Estrogen Receptors and Antiestrogen Therapies
    Ian Mitchelle S. de Vera, Udayanga S. Wanninayake, T. Burris · 2018 · Estrogen Receptor and Breast Cancer
52. Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations
    Rinath M. Jeselsohn, Johann S. Bergholz, Matthew J Pun, MacIntosh Cornwell, Weihan Liu, Agostina Nardone, Tengfei Xiao, Wěi Li, Gilles Buchwalter, Ariel Feiglin et al. · 2018 · SSRN Electronic Journal
53. A ternary switch determines ERα LBD conformation
    Daniel P. McDougal, Jordan L. Pederick, Scott J. Novick, Blagojce Jovcevski‬, Annmaree K. Warrender, Bruce D. Pascal, Patrick R. Griffin, John B. Bruning · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
54. Investigating the potential mechanism of bisphenols on neurodegeneration through network toxicology and molecular docking
    Hui Liu, Mengyao Tang, Luqiao Che, Jianing Lu, Liping Zhang · 2025 · NAM journal.
55. Selective Glucocorticoid Receptor Modulators of Immune Checkpoint Function
    Robin R. Kobylski, Charles K. Min, Jerome C. Nwachukwu, Marcel Koenig, Haotian Zhang, Lizbeth Moncada, Thomas Venables, Bin-Bin Schell, William J. Stein, Claudia McCown et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
56. Native Top-Down Mass Spectrometry Links Structure and Gas-Phase Stability of ERα-LBD
    Kanchan Pathak, Emma C. Fink, Delaynie Brinkman, K.W. Nettles, Sean William Fanning, Fábio Pereira Gomes · 2026 · Journal of the American Society for Mass Spectrometry
57. BindingDB Entry 50039738: Identification and structure-activity relationships of a novel series of estrogen receptor ligands based on 7-thiabicyclo[2.2.1]hept-2-ene-7-oxide.
    BindingDB · 2013 · UC San Diego
58. BindingDB Entry 50032091: Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells.
    BindingDB · 2011 · UC San Diego
59. BindingDB Entry 50014118: GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer.
    BindingDB · 2022 · UC San Diego
60. BindingDB Entry 50048166: Synthesis of novel steroidal agonists, partial agonists, and antagonists for the glucocorticoid receptor.
    BindingDB · 2018 · UC San Diego
61. BindingDB Entry 50023494: Drug discovery of N-methyl-pyrazole derivatives as potent selective estrogen receptor degrader (SERD) for the treatment of breast cancer.
    BindingDB · 2026 · UC San Diego
62. Data for "Bile acids target an exposed cavity in the glucocorticoid receptor modulating receptor self-assembly, chromatin binding and transcriptional activity"
    Alba Jiménez‐Panizo, Thomas A. Johnson, Kaustubh Wagh, Andrea Alegre‐Martí, Inés Montoya-Novoa, Agustina L. Lafuente, Ulrich Eckhard, Luis Angel Rodríguez‐Lumbreras, Le Hoang, Martín Stortz et al. · 2025 · Zenodo (CERN European Organization for Nuclear Research)
63. BindingDB Entry 50019968: Design, synthesis, biological evaluation and crystal structure determination of dual modulators of carbonic anhydrases and estrogen receptors.
    BindingDB · 2024 · UC San Diego
64. BindingDB Entry 50031307: Isoflavonoids from Erythrina poeppigiana: evaluation of their binding affinity for the estrogen receptor.
    BindingDB · 2010 · UC San Diego
65. BindingDB Entry 50002786: Recent advances in peptidomimetics antagonists targeting estrogen receptor α-coactivator interaction in cancer therapy.
    BindingDB · 2020 · UC San Diego
66. BindingDB Entry 50044138: Triaryl-substituted Schiff bases are high-affinity subtype-selective ligands for the estrogen receptor.
    BindingDB · 2015 · UC San Diego
67. Activation of estrogen receptor-alpha by nitrite
    Geoffrey B. Storchan · 2012 · DigitalGeorgetown (Georgetown University Library)